Zhejiang Anglikang Pharmaceutical Co.,Ltd.

The company is a modern pharmaceutical enterprise integrating pharmaceutical intermediates, APIs and pharmaceutical preparations, featuring cardiovascular, oral cephalosporins, nephropathy, and narcotic analgesics. The company was restructured and established in 2001. After more than 20 years of development, it has now built major production bases such as Shengzhou in Zhejiang, Yancheng in Jiangsu, Sanming in Fujian, and Ji'an in Jiangxi, and has more than 10 holding subsidiaries. It is now on the list of China's top 100 pharmaceutical industry, and was listed on the Shenzhen Stock Exchange in October 2018. The company's main business is pharmaceutical manufacturing business, which mainly includes R&D, production and sales of chemical raw materials, chemical preparations, pharmaceutical excipients and specialty intermediates. The main products produced by the company include anti-infective, cardiovascular, urinary (nephropathy), anesthetic pain, anti-androgenic hormones, medicinal hollow capsule products, and specialty intermediates. Corporate honors: Zhejiang Province's “Contract-abiding and Credit-abiding” Enterprise Certificate AA; Zhejiang Province's “Contract-abiding and Credit-abiding” Enterprise Class AA; 2017 Zhejiang Famous Trademark Certificate; 2017 Shaoxing Advanced Company; 2017 Shaoxing 2nd Anti-Drug Association Member Unit; 2017 Shaoxing City Honest and Law-abiding Demonstration Enterprise, etc.